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Abstract
Objective: The Dietary Inﬂammatory Index (DII)TM, which was developed to
characterize the inﬂammatory potential of a person’s diet, has been shown to be
associated with inﬂammatory conditions such as cancer. The present study aimed
to investigate the association between DII scores and colorectal adenoma (CRA),
a pre-cancerous condition.
Design: Responses to baseline dietary questionnaires were used calculate DII
scores. In a cross-sectional study design, the association between DII scores and
CRA prevalence was determined in men and women separately using logistic
regression models.
Setting: Ten cancer screening centres across the USA.
Subjects: Participants were those included in the screening arm of the Prostate,
Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Results: Among the 44 278 individuals included in these analyses, men with diets
in the most inﬂammatory quartile of DII scores had higher odds of all types of
CRA (advanced, non-advanced and multiple (>1)) compared with those with diets
in the least inﬂammatory quartile of DII scores. In fully adjusted models, compared
with those with DII scores in quartile 1 (least inﬂammatory), males with DII
scores in quartile 3 (adjusted odds ratio (aOR) = 1·28; 95 % CI 1·12, 1·47) and
quartile 4 (aOR = 1·41; 95 % CI 1·23, 1·62) were more likely to have prevalent distal
CRA. Higher DII scores, representing a more inﬂammatory diet, also were weakly
associated with a higher prevalence of CRA in women.
Conclusions: Implementing an anti-inﬂammatory diet may be an effective means
of primary prevention of CRA, especially in men.

The biological effects of diet on inﬂammation are complex. Very simply, oxidative stress, which can occur after
the ingestion of an energetically dense (i.e. high in fat
or high in simple carbohydrates) meal, results in the
production and release of free radicals and reactive
oxygen and nitrogen species into the tissues. This in turn
can lead to damaged tissues and inﬂammation(1,2).
Conversely, foods high in antioxidants and ﬂavonoids,
such as fruits and vegetables, reduce inﬂammation by
scavenging free radicals, inhibiting pro-oxidant enzymes,
binding free radicals and possibly modulating the
expression of pro-inﬂammatory molecules(3,4). Prolonged
and unchecked inﬂammatory conditions create a microenvironment favourable for tumour growth and progression(5). Identifying dietary factors that promote a less
*Corresponding author: Email alhaslam@uga.edu
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favourable environment for inﬂammatory conditions, in
light of the association between diet and inﬂammation,
may be one way to minimize the incidence of adenomas
and cancer.
The Dietary Inﬂammatory Index (DII)TM was developed
to characterize the inﬂammatory nature of a person’s diet,
with scores on a continuum from maximally inﬂammatory
to maximally anti-inﬂammatory. This index has been
shown to be associated with concentrations of several
circulating inﬂammatory proteins, including C-reactive
protein(6) and IL-6(7), in prospective and case–control
studies. Previously published work has shown that
a more inﬂammatory diet, as reﬂected by a higher DII
score, is associated with a higher prevalence of asthma
(an inﬂammatory condition)(7), pancreatic cancer(8) and
© The Authors 2017
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prostate cancer in hospital-based case–control studies.
Most recently, higher scores on this index have been
found to be associated with a higher incidence of colorectal cancer in the Women’s Health Initiative and the Iowa
Women’s Health Study(10,11). Another recent study showed
an association between DII scores and polymorphisms
in the gene for the anti-inﬂammatory cytokine IL-4
(rs2243250)(12). In that study, individuals with a more
inﬂammatory diet and the IL-4 polymorphism had a higher
risk of colorectal cancer than those with the polymorphism
who consumed a less inﬂammatory diet. Less favourable
DII scores are reﬂective of diets lower in antioxidants
and higher in pro-oxidants. This imbalance could lead to
oxidative stress and genotoxic damage, which may then
lead to abnormal growths and cancers in the colon(13).
Anti-inﬂammatory dietary factors exert their effects
through the modulation and inhibition of inﬂammatory
proteins and cytokines, such as transforming growth
factor-β, cyclooxygenase-2, IFN-γ and NF-κB(14).
While these studies have shown an association between
the incidence of colorectal cancer and a more inﬂammatory
diet, it is unknown whether colorectal adenomas (CRA),
which are precursors for colorectal cancer, are associated
with a more inﬂammatory diet. The purpose of the current
study was to examine whether or not a more inﬂammatory
diet, as indicated by a higher DII score, was associated with
the prevalence of CRA in a large cohort of older adults.

Methods
Study population
Data were collected as part of the Prostate, Lung, Colorectal,
and Ovarian (PLCO) Cancer Screening Trial and have been
described previously in detail(15–18). In short, over 148 000
men and women, aged 55–74 years, were recruited between
1993 and 2000 at one of ten screening centres across the
USA (Birmingham, AL; Denver, CO; Detroit, MI; Honolulu,
HI; Marshﬁeld, WI; Minneapolis, MN; Pittsburgh, PA; Salt
Lake City, UT; St Louis, MO; and Washington, DC). Each
participant who was randomly assigned to the screening
arm was asked to complete a detailed questionnaire at
baseline with questions regarding sociodemographic
characteristics, diet, physical activity, personal and family
cancer history, smoking history and use of selected
medications. Those with an abnormal ﬁnding on ﬂexible
sigmoidoscopy examination were referred for endoscopic
follow-up. Results from diagnostic screening and treatment,
including surgical procedures, were gathered by trained
medical abstractors from each participant’s medical record.
Institutional review board approval was obtained from the
National Cancer Institute and the ten screening centres
involved with the study. Informed consent was provided
by all study participants.
Data from screening-arm participants who returned the
baseline questionnaire, which had questions regarding

sociodemographic information, health history, medications and physical activity, were used for the present
secondary analyses (n 75 611). Participants were excluded
in this order: if ﬂexible sigmoidoscopy examination was
not adequate (deﬁned as insertion to at least 50 cm with
>90 % of mucosa visible or suspect lesion found) or not
done (n 18 148); had a positive ﬂexible sigmoidoscopy
examination but had either no follow-up or ambiguous
follow-up (n 3717); had a personal history of any cancer
(except melanoma) or did not know their personal history
of cancer before the dietary questionnaire (n 2081); had
ulcerative colitis, Crohn’s disease, Gardner’s syndrome or
familial polyposis (n 652); did not complete the dietary
questionnaire (n 4937); had eight or more missing
responses on the dietary questionnaire (n 385); had
extreme energy intake reported on the dietary questionnaire (top or bottom 1 % of sex-speciﬁc energy intake;
n 796); or did not specify race (n 9). Participants were
further excluded if they were missing data on key
variables (BMI, education, physical activity or smoking
status; n 23). The ﬁnal sample size was 44 278.
Adenomas
Any prevalent adenoma, not including hyperplastic
polyps, in the distal region (rectum to the splenic ﬂexure)
at baseline was the main outcome of interest. Advanced
adenomas were those that were villous or tubulovillous
in nature, large (≥1·0 cm), or displayed severe or highgrade dysplasia. Physician and non-physician examiners
followed standardized procedures to determine visual size
estimates at sigmoidoscopy.
Dietary data
Questionnaire
Dietary data were collected using the dietary questionnaire developed by the National Cancer Institute(19).
The sixteen-page questionnaire asked about the usual
frequency and portion size of 137 food items and ten
dietary supplements over the year prior to enrolment. The
dietary questionnaire has been shown to have good
reliability and has been validated against both the Block
and Willett FFQ(19). Values for daily nutrients and food
groups were determined from the national dietary data
and the Pyramid food group servings database from the
1994–1996 Continuing Survey of Food Intakes by Individuals with a method developed by Subar et al.(19).
Dietary Inﬂammatory Index
The DII is a tool used to score the inﬂammatory nature
of an overall diet and was developed using data from
individuals consuming diverse diets(20). Forty-ﬁve food/
nutrient parameters were identiﬁed in the original index as
being associated with six cytokines important in determining inﬂammatory response. Design and development
of the DII have been described in detail previously(20,21).

Dietary Inﬂammatory Index and colorectal adenoma prevalence

To calculate the DII score, dietary intake data from each
participant in the PLCO cohort were linked to a previously
developed global database that was created by calculating
the global mean and global standard deviation for each of
the forty-ﬁve foods/nutrients for eleven countries around
the world(21). A Z-score for each dietary factor was
created for each PLCO participant by subtracting the
global standard mean from the individual’s reported
amount of consumed food/nutrient, and dividing this
value by its respective global standard deviation. This
value was then converted to a percentile score to minimize
the effect of ‘right skewing’ (fewer observations with
higher intakes of dietary factors), which often occurs
with dietary data.
The ‘inﬂammatory effect score’ for each dietary factor
was calculated previously, based on results from experimental, prospective cohort, case–control, cross-sectional,
animal experimental and cell-culture studies(21). The
dietary factor percentile score for each participant in the
PLCO cohort was multiplied by its respective ‘inﬂammatory effect score’ to derive a ‘food-speciﬁc dietary inﬂammatory score’. Each of the ‘food-speciﬁc dietary
inﬂammatory scores’ were summed to derive an overall
dietary inﬂammatory score, where negative scores are less
inﬂammatory and positive scores are more inﬂammatory.
Scores are based on both food and nutrient intakes. For
these analyses, thirty-seven of the forty-ﬁve foods or
nutrients from the original DII were available for use.
Pro-inﬂammatory dietary factors included: vitamin B12,
carbohydrate, cholesterol, energy, total fat, Fe, protein,
SFA and trans-fat. Anti-inﬂammatory dietary factors
included: vitamin B6, β-carotene, caffeine, ﬁbre, folic acid,
vitamins A, D, C and E, niacin, riboﬂavin, thiamin, Mg, Se,
Zn, MUFA, n-3 fatty acids, n-6 fatty acids, PUFA, ﬂavan3-ols, ﬂavones, ﬂavonols, ﬂavonones, anthocyanidins,
isoﬂavones, green/black tea, alcohol and onion. DII scores
were calculated per 4184 kJ consumed to account for
inter-individual differences in energy intake, which is also
termed the Energy-Density DII (E-DII). E-DII scores for the
PLCO screening-arm population ranged between −5·87
(maximally anti-inﬂammatory) and 5·58 (maximally
pro-inﬂammatory). For analytical purposes, the E-DII
scores were then categorized into quartiles.
Covariate data
Potential covariates included: smoking (never, current, or
former); sex (male or female); self-report of race (black,
white, Asian or other); and non-steroidal anti-inﬂammatory
use (regular use of aspirin/aspirin-containing or ibuprofen/
ibuprofen-containing products or not). BMI (= [weight
(kg)]/[height (m)]2) was categorized as underweight
( <18·5 kg/m2), normal (18·5–24·9 kg/m2), overweight (25·0–
30·0 kg/m2) or obese (>30·0 kg/m2), and was based on selfreported height and weight. Physical activity was categorized
as vigorous activities for <2 h/week (low) v. ≥2 h/week
(high) to stay consistent with current recommendations(22).
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Hormone status was categorized as never, current (ever
taken or currently taking female hormones), former or
unknown. Education was categorized into less than high
school, high-school diploma, some college or post highschool training, and college or graduate degree. Age at
randomization, alcohol intake (g/d), ﬁbre intake (g/d), Ca
intake (food and supplements; mg/d) and energy intake
(kJ/d; kcal/d) were left as continuous variables.
Statistical analysis
Means and frequencies, with their respective standard
deviations and percentages, were calculated for continuous and categorical characteristics, stratiﬁed by E-DII
score quartiles. The χ2 test and ANOVA were used to
determine differences, if any, in descriptive characteristics
between quartiles of E-DII score. Normal distribution was
assessed with histograms (QQ plot or Shapiro–Wilk test)
for each variable.
Multivariable logistic regression was used to calculate the
odds of prevalent CRA for different quartiles of E-DII
score(9). Separate models were created for adenoma type
(all prevalent, advanced, non-advanced or multiple (>1)
adenoma). Regression models were initially adjusted for sex,
race, smoking, age, physical activity, education, hormone
status, regular use of aspirin/aspirin-containing or ibuprofen/ibuprofen-containing products, and daily Ca, energy
and alcohol intakes. Additionally, an interaction term for
sex and E-DII score category was included. All potential
covariates and interaction terms were included in the initial
model and then were evaluated for variable selection; if they
were not signiﬁcant in the model (P < 0·20), they were
removed if their exclusion did not result in a lower Akaike
information criterion statistic(23). The most parsimonious
model, indicated by a lower Akaike information criterion
value, was selected. Covariates used in calculating the
overall adenoma odds were used for subgroup analyses.
The models were stratiﬁed by sex if the interaction between
sex and E-DII score was signiﬁcant (P < 0·20). Wald χ2 was
used to test for trends across E-DII categories. Models were
also stratiﬁed by BMI status (overweight/obese v. normal/
underweight) or smoking status (never v. former/current).
All analyses were performed using the statistical software
package SAS version 9.4 using a P value <0·05 to indicate
signiﬁcance, unless otherwise indicated.

Results
Descriptive characteristics for the quartiles of the E-DII are
presented in Table 1. Compared with quartile 4, quartile 1
(least inﬂammatory) had a higher percentage of females
(65·0 v. 26·0 %), Asians (7·4 v. 1·6 %), individuals with a
college education (45·5 v. 27·7 %), individuals with a high
amount of physical activity (68·2 v. 42·4 %), never smokers
(52·4 v. 40·8 %) and individuals with a normal BMI (41·5 v.
22·4 %). Women in quartile 1 (least inﬂammatory) were
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Table 1 Baseline characteristics of the screening-arm participants (n 44 278) by quartile of Energy-Density Dietary Inflammatory Index
(E-DII) score; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, USA, 1993–2000
Quartile 1
Quartile 4
(least inflammatory)
Quartile 2
Quartile 3
(most inflammatory)
(E-DII < −2·93)
(E-DII = −2·93 to −1·80) (E-DII = −1·81 to −0·45)
(E-DII > −0·45)
Characteristic
Categorical variables
Sex
Male
Female
Race
White
Black
Asian
Other
Education
College
Some college
High school
Less than high school
Physical activity†
High
Low
Smoking
Never
Current
Former
Anti-inflammatory use‡
Yes
No
Hormone therapy (females)
Current
Former
Never
Unknown
BMI (kg/m2)
0–18·5
18·5–25·0
25·0–30·0
>30·0
Missing (n 430)

Continuous variables
Age (years)
Ca intake (supplements and food; mg/d)
Energy intake (kJ/d)
Alcohol intake (g/d)
Fibre intake (g/d)

n

%

n

%

n

%

n

%

3879
7190

35·0
65·0

5273
5797

47·6
52·4

6444
4625

58·2
41·8

8192
2878***

74·0
26·0

9625
400
815
229

87·0
3·6
7·4
2·1

10 107
364
381
218

91·3
3·3
3·4
2·0

10 141
402
284
242

91·6
3·6
2·6
2·2

10 195
442
183
250***

92·1
4·0
1·6
2·3

5034
3616
2034
385

45·5
32·7
18·4
3·5

4389
3815
2290
576

39·6
34·5
20·7
5·2

4012
3732
2644
681

36·2
33·7
23·9
6·2

3067
3820
3042
1141***

27·7
34·5
27·5
10·3

7545
3524

68·2
31·8

6678
4392

60·3
39·7

5957
5112

53·8
46·2

46 949
6367***

42·4
57·6

5801
569
4694

52·4
5·1
42·4

5703
759
4608

51·5
6·9
41·6

5214
1068
4787

47·1
9·6
43·2

4512
1746
4812***

40·8
15·8
43·5

2272
8797

20·5
79·5

2187
8883

19·8
80·2

2254
8815

20·4
79·6

2216
8854

20·0
80·0

4069
1115
1976
23

56·6
15·5
27·5
0·3

3083
908
1779
20

53·2
15·7
30·7
0·4

2377
715
1513
17

51·4
15·5
32·7
0·4

1331
468
1064
9***

46·3
16·3
37·0
0·3

100
4592
4318
2059

0·9
41·5
39·0
18·6

70
3725
4819
2453

0·6
33·6
43·6
22·2

59
3223
4973
2814

0·5
29·1
44·9
25·4

40
2478
5194
3358***

0·4
22·4
46·9
30·3

Mean

SD

Mean

SD

Mean

SD

Mean

SD

62·9
1349·7
7684·3
8·4
26·8

5·4
578·6
2717·9
14·1
10·8

62·8
1256·2
8203·2
9·0
24·7

5·3
587·9
3026·7
17·0
10·1

62·4
1212·1
8758·8
10·9
22·6

5·2
601·5
3273·1
21·0
9·3

61·7***
5·1
1168·4*** 641·6
9939·9*** 3811·6
15·9***
34·9
19·9***
8·1

***P < 0·0001; χ2 test for categorical and ANOVA for continuous variables.
†Vigorous activities for <2 h/week (low) v. ≥2 h/week (high).
‡Regular use of aspirin/aspirin-containing or ibuprofen/ibuprofen-containing products or not.

more likely to be current hormone users than women in
quartile 4 (most inﬂammatory; 56·6 v. 46·3 %). Additionally, compared with those in quartile 4, those in quartile 1
were older (62·9 v. 61·7 years), had a higher intake of
Ca (1349·7 v. 1168·4 mg/d) and a lower energy intake
(7684·3 v. 9939·9 kJ/d).
Prevalent distal adenoma
There was signiﬁcant interaction between E-DII score and
sex (P = 0·02), so models for prevalent distal adenoma
were stratiﬁed by sex. In fully adjusted models (adjusted

for race, education, smoking status, BMI, age and Ca
intake), compared with those with E-DII scores in quartile
1 (least inﬂammatory), males with E-DII scores in quartile
3 (adjusted odds ratio (aOR) = 1·28; 95 % CI 1·12, 1·47) and
quartile 4 (aOR = 1·41; 95 % CI 1·23, 1·62; Table 2) were
more likely to have prevalent distal CRA. Males with E-DII
scores in quartile 3 (aOR = 1·34; 95 % CI 1·12, 1·60) and
quartile 4 (aOR = 1·42; 95 % CI 1·19, 1·68) also were more
likely to have a non-advanced adenoma, compared with
those in the lowest quartile of E-DII scores. Males with
E-DII scores in quartile 4 (aOR = 1·39; 95 % CI 1·13, 1·71;

Dietary Inﬂammatory Index and colorectal adenoma prevalence
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Table 2 Associations between prevalent colorectal adenoma and quartile of Energy-Density Dietary Inflammatory Index (E-DII) score† in
the screening-arm participants (n 44 255) by sex‡; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, USA, 1993–2000
Quartile 2
Quartile 1 (least
inflammatory; reference) OR
Men (n 23 788)§
All distal adenoma
No. of cases
Multivariable-adjusted OR
Non-advanced adenoma
No. of cases
Multivariable-adjusted OR
Advanced adenoma
No. of cases
Multivariable-adjusted OR
Multiple adenomas (>1)
No. of cases
Multivariable-adjusted OR
Women (n 20 467)║
All distal adenoma
No. of cases
Multivariable-adjusted OR
Non-advanced adenoma
No. of cases
Multivariable-adjusted OR
Advanced adenoma
No. of cases
Multivariable-adjusted OR
Multiple adenomas (>1)
No. of cases
Multivariable-adjusted OR

95 % CI

Quartile 3
OR

95 % CI

Quartile 4 (most
inflammatory)
OR

95 % CI

Wald χ2
P trend
<0·0001

(95 % CI)

327
1·00

496
741
1·06 0·92, 1·23 1·28 1·12, 1·47

(95 % CI)

193
1·00

310
449
1·14 0·95, 1·38 1·34 1·12, 1·60

(95 % CI)

129
1·00

184
284
0·97 0·77, 1·22 1·21 0·98, 1·50

(95 % CI)

80
1·00

136
193
1·18 0·89, 1·56 1·32 1·01, 1·72

(95 % CI)

469
1·00

358
356
0·90 0·78, 1·04 1·13 0·98, 1·31

(95 % CI)

291
1·00

222
217
0·92 0·77, 1·10 1·14 0·95, 1·38

(95 % CI)

177
1·00

132
135
0·86 0·68, 1·08 1·09 0·86, 1·38

(95 % CI)

91
1·00

60
69
0·77 0·55, 1·07 1·08 0·79, 1·49

1·41

1091
1·23, 1·62

1·42

630
1·19, 1·68

1·39

441
1·13, 1·71

1·63

327
1·26, 2·11

1·08

225
0·91, 1·29

1·17

142
0·94, 1·45

0·96

83
0·72, 1·27

1·28

57
0·90, 1·82

0·0002
0·0003
0·0004

0·03
0·07
0·29
0·06

Significant (P < 0·05) results are indicated in bold font.
†Quartile 1, E-DII < −2·93; quartile 2, E-DII = −2·93 to −1·80; quartile 3, E-DII = −1·81 to −0·45; quartile 4, E-DII > −0·45.
‡Interaction P values for sex × E-DII score for adenoma (overall), non-advanced adenoma, advanced adenoma and multiple (>1) adenoma are, respectively,
0·03, 0·16, 0·20 and 0·29.
§Adjusted for BMI, education, smoking status, race, Ca intake, alcohol intake and age.
║Adjusted for BMI, smoking, race, hormone status, total daily energy intake, Ca intake, alcohol intake and age.

Table 2) were more likely to have advanced CRA, compared with those with E-DII scores in quartile 1. Males
with E-DII scores in quartile 3 (aOR = 1·32; 95 % CI 1·01,
1·72) and quartile 4 (aOR = 1·63; 95 % CI 1·26, 2·11) were
more likely to have more than one distal CRA, compared
with those with E-DII scores in quartile 1. In fully adjusted
models, there were no differences in the odds of CRA
(advanced, non-advanced or multiple (>1)) between
E-DII quartile 1 and E-DII quartile 4 in females. However,
there was a trend that higher E-DII scores were associated
with higher odds of adenoma, overall.
When results were stratiﬁed by smoking status or BMI
classiﬁcation, the odds of adenoma among overweight/
obese men with the most inﬂammatory diet v. those with
the least inﬂammatory diet (aOR = 1·39; 95 % CI 1·18, 1·63)
were similar to those of normal/underweight men
(aOR = 1·50; 95 % CI 1·14, 1·96; data not shown).
However, the odds of adenoma among male smokers with
the most inﬂammatory diet v. the least inﬂammatory diet
(aOR = 1·63; 95 % CI 1·38, 1·93) were higher than those of
men who did not smoke (aOR = 1·22; 95 % CI 0·97, 1·53;
data not shown). Females showed similar patterns
(smokers aOR = 1·43; 95 % CI 1·12, 1·83; non-smokers
aOR = 0·97; 95 % CI 0·76, 1·25; data not shown).

Discussion
In this large cohort of men and women, enrolled as part of
the PLCO screening arm, we sought to investigate the
association between CRA and E-DII score and found that
a more inﬂammatory diet was associated with distal CRA
prevalence in men, and to a limited extent in women.
Speciﬁcally, males who consumed a more inﬂammatory
diet were more likely to have non-advanced adenomas,
advanced adenomas and multiple (>1) adenomas than
men who consumed a less inﬂammatory diet.
It is believed that inﬂammation promotes an environment
that increases genetic mutations and disables the mechanisms that repair these errors(24). There also is evidence that
inﬂammation may promote growth factors that enhance
tumour growth, particularly through enhanced angiogenesis(22). Further, a vicious cycle is created in that tumour
cells produce cytokines that attract leucocytes, which further promote inﬂammation(5). Higher systemic concentrations of inﬂammatory cytokines may then lead to the
development of CRA(25). Diet can affect systemic inﬂammation both positively and negatively. A high intake of
energy and certain types of fat (e.g. trans-fats) may lead to
pro-inﬂammatory states(26,27), while fruits and vegetables
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contain antioxidants that counteract inﬂammation . The
DII has recently been developed as a way for researchers to
characterize the overall inﬂammatory nature of diet(6). This
index has been shown to be associated with inﬂammatory
conditions, such as colon, prostate and pancreatic cancers,
and asthma(8,9,11,12,29), as well as circulating inﬂammatory
proteins(6,7).
Findings of the present study are generally consistent
with those from other studies that have found lower odds
of prevalent CRA among those who consume a ‘healthy’
diet(29,30). For example, men with higher scores on several
dietary indices (Healthy Eating Index, Mediterranean diet,
Dietary Approach to Stop Hypertension) were less likely
to have a prevalent CRA compared with men consuming a
less healthy diet(29). These results suggest that there may
be a common element, such as an anti-inﬂammatory
dimension, among the dietary indices which confers
adenoma-protective effects, and that the speciﬁc type of
diet may be less important than this common beneﬁcial
element (e.g. anti-inﬂammatory dimension). Indeed, for
several of the dietary indices mentioned, better scores
have been associated with lower concentrations of
inﬂammatory markers(31,32).
It is interesting that lower E-DII scores, indicating a
less-inﬂammatory diet, were not strongly associated
with distal CRA prevalence in women, although there
was a trend across quartiles of higher odds of CRA
with higher E-DII scores. Some previous studies have
shown that women with more inﬂammatory diets, as
reﬂected by higher DII scores, were more likely to have
developed colorectal cancer, compared with those with
less inﬂammatory diets(10,11). However, another larger
study using individuals in the American Association of
Retired Persons Diet and Health Study found that the
association between a less inﬂammatory diet and lower
risk of colorectal cancer was signiﬁcant only in men(33).
Since adenomas are precursors to cancer, we expected
to ﬁnd a positive association between E-DII scores
and CRA prevalence in women. However, dietary
predictors for adenomas may not be the same as dietary
predictors for colon cancer in women. It has been
estimated that only half of studies on the association
between diet indices (e.g. Mediterranean diet and Healthy
Eating Index) and colorectal cancers report sex-speciﬁc
risks(34), suggesting that the current literature may not
fully capture the effects of diet on adenoma prevalence
or cancer incidence in males and females, individually.
Of those studies that have reported on dietary factors
for CRA in men and women separately, several did not
ﬁnd a protective effect of diet in women(29,30,35). Another
explanation for the discrepancy in ﬁndings between the
current study and previous studies may have to do
with lower (less inﬂammatory) E-DII scores in the
present study (−2·1 (SD 1·6) v. −0·9 (SD 2·0); P < 0·0001(11)).
The generally lower scores in the present study may
have limited the ability to see beneﬁcial dietary effects

because the diets were generally ‘adequate’ for adenoma
prevention.
To further explore the association between E-DII scores
and adenoma status in women, sensitivity analyses were
performed combining quartiles 1 and 2 and comparing
the odds of adenoma with those of quartile 3 or 4. Alternatively, cut points used in another study using the E-DII
also were used(9). In both instances, results were similar to
those presented in Table 2. The results appear to have
a curvilinear response in women, which may suggest
a differential effect of diet between sexes. A possible
explanation is that these analyses were cross-sectional
in nature and those who were consuming the most
anti-inﬂammatory diet were doing so because they had
concerns about a higher risk of adenoma. Another
possible explanation is that women who have very
anti-inﬂammatory diets also engage in other behaviours
not fully accounted for in the analyses, which weaken the
effect of a healthy diet, or because women misestimate
their actual intake because of social desirability and underreport total fat and energy intakes(36). Differences in actual
v. reported intakes between men and women may also
at least partly explain why the E-DII was associated with
adenoma in men but not in women.
It is unknown to what extent the results of the current
study can be applied to proximal adenomas. One study
found that the risk adenoma and diet (ﬁbre and fruit and
vegetables) was lower for adenomas occurring in the
proximal v. distal region(37). However, results from other
studies, including a literature review, are unclear as to
whether or not there are anatomical site differences in
the effects of diet on cancer or adenoma development or
occurrence(33,38,39). Future research would need to be
done to more fully understand the association between
diet and adenoma occurrence in site-speciﬁc areas.
One of the strengths of the present study is the large,
diverse cohort of individuals with varied dietary habits,
enabling the analysis of adenoma outcomes across a broad
spectrum of food intakes. Another study strength is the
novel way to characterize the inﬂammatory nature of diet.
Inﬂammation is an important factor in disease occurrence
and the E-DII is the ﬁrst index to be developed speciﬁcally
for measuring the inﬂammatory potential of an individual’s
diet. Finally, participants in the PLCO study were screened
uniformly, allowing for equal opportunity of adenoma
detection.
A limitation of the study is that the E-DII was not able to
fully determine the inﬂammatory nature of the diets due
to some of the E-DII components not being included in
the dietary questionnaire (e.g. eugenol, garlic, ginger,
saffron, turmeric, pepper, rosemary and thyme/oregano).
However, most items for the E-DII were included in the
calculations and these represented the most commonly
consumed foods/nutrients. Another limitation to these
analyses is recall bias, most notably for the dietary recall.
This may have resulted in biased estimates, particularly
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among women where the potential for misclassiﬁcation
was greater, thus resulting in estimates closer to the null.

Conclusion
A more inﬂammatory diet was associated with a higher
risk of CRA, particularly in men. The results for women
were less conclusive. Therefore, future research should
use large prospective studies to replicate these ﬁndings
with a focus on gender differences and the potential for
recall bias in inﬂuencing these associations. Also, future
work could be done to determine whether these results
apply to incident or recurrent adenomas, as well as adenomas in the proximal region of the colon. Results from
the present study support an inﬂammatory mechanism for
the development of CRA. From a public health perspective, future work should focus on helping individuals
understand and incorporate anti-inﬂammatory elements
into their diet.
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